Revenue by source
Product$60.96BHuman Pharmaceutical Products$0.00Endocrinology$0.00Collaboration and Other Revenue$4.22BNeuroscience$0.00Animal Health Products$0.00Oncology$0.00Cardiovascular$0.00Other Pharmaceuticals$0.00
| Segment | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Product | - | - | - | - | - | - | - | - | $20.38B | $22.69B | $25.96B | $25.46B | $28.81B | $40.75B | $60.96B |
| Human Pharmaceutical Products | $23.60B | - | - | - | - | $18.06B | $19.79B | $12.35B | - | - | - | - | - | - | - |
| Endocrinology | - | $6.81B | $7.30B | $6.94B | $7.04B | - | - | - | - | - | - | - | - | - | - |
| Collaboration and Other Revenue | - | - | - | - | - | - | - | - | $1.94B | $1.85B | $2.36B | $3.08B | $5.31B | $4.29B | $4.22B |
| Neuroscience | - | $7.58B | $7.22B | $3.60B | $2.94B | - | - | - | - | - | - | - | - | - | - |
| Animal Health Products | $681.70M | $2.04B | $2.15B | $2.35B | $3.18B | $3.16B | $3.09B | $1.62B | - | - | - | - | - | - | - |
| Oncology | - | $3.28B | $3.27B | $3.39B | $3.51B | - | - | - | - | - | - | - | - | - | - |
| Cardiovascular | - | $2.63B | $2.92B | $3.05B | $3.07B | - | - | - | - | - | - | - | - | - | - |
| Other Pharmaceuticals | - | - | $249.30M | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue by country
UNITED STATES$43.48BEurope$11.56BNon-US$6.06BJAPAN$2.13BOther Foreign Countries$0.00CHINA$1.95BEndocrinology$0.00Neuroscience$0.00Oncology$0.00Cardiovascular$0.00Animal Health Products$0.00Other Pharmaceuticals$0.00
| Segment | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| UNITED STATES | $12.31B | - | $9.13B | $10.10B | $11.51B | $12.79B | - | $12.72B | $14.23B | $16.81B | $18.19B | $21.79B | $30.38B | $43.48B |
| Europe | $4.26B | - | $4.51B | $3.94B | $3.77B | $3.94B | $4.23B | $3.77B | $4.19B | $4.78B | $4.30B | $6.17B | $6.92B | $11.56B |
| Non-US | $3.78B | - | - | - | $3.62B | $3.72B | $14.64B | - | - | $2.70B | $2.85B | $2.95B | $4.27B | $6.06B |
| JAPAN | $2.25B | - | $2.03B | $2.03B | $2.33B | $2.42B | $2.49B | $2.55B | $2.58B | $2.37B | $1.75B | $1.67B | $1.81B | $2.13B |
| Other Foreign Countries | - | - | $3.95B | $3.88B | - | - | - | $3.28B | $2.42B | - | - | - | - | - |
| CHINA | - | - | - | - | - | - | - | - | $1.12B | $1.66B | $1.45B | $1.54B | $1.66B | $1.95B |
| Endocrinology | - | $7.30B | - | - | - | - | - | - | - | - | - | - | - | - |
| Neuroscience | - | $7.22B | - | - | - | - | - | - | - | - | - | - | - | - |
| Oncology | - | $3.27B | - | - | - | - | - | - | - | - | - | - | - | - |
| Cardiovascular | - | $2.92B | - | - | - | - | - | - | - | - | - | - | - | - |
| Animal Health Products | - | $2.15B | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Pharmaceuticals | - | $249.30M | - | - | - | - | - | - | - | - | - | - | - | - |